Free Trial

EssilorLuxottica (ESLOY) Stock Forecast & Price Target

EssilorLuxottica logo
$146.00 -2.68 (-1.80%)
As of 03:52 PM Eastern

EssilorLuxottica - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
0

Based on 1 Wall Street analysts who have issued ratings for EssilorLuxottica in the last 12 months, the stock has a consensus rating of "Hold." Out of the 1 analysts, 1 has given a hold rating for ESLOY.

Consensus Price Target

N/A

Get the Latest News and Ratings for ESLOY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for EssilorLuxottica and its competitors.

Sign Up

ESLOY Analyst Ratings Over Time

TypeCurrent Forecast
7/10/24 to 7/10/25
1 Month Ago
6/10/24 to 6/10/25
3 Months Ago
4/11/24 to 4/11/25
1 Year Ago
7/11/23 to 7/10/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus Rating
Hold
Hold
Hold
Hold

ESLOY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ESLOY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

EssilorLuxottica Stock vs. The Competition

TypeEssilorLuxotticaMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.80
2.54
Consensus RatingHoldModerate BuyModerate Buy
Predicted UpsideN/A8,514.90% Upside9.51% Upside
News Sentiment Rating
Positive News

See Recent ESLOY News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/29/2025Royal Bank Of Canada
4 of 5 stars
P. Dadhania
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Moderate Buy
12/3/2024UBS Group
3 of 5 stars
S. Tibaldi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 04:52 PM ET.


Should I Buy EssilorLuxottica Stock? ESLOY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, July 9, 2025. Please send any questions or comments about these EssilorLuxottica pros and cons to contact@marketbeat.com.

EssilorLuxottica
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in EssilorLuxottica Société anonyme:

  • The current stock price is around $140.61, showing a recent increase, which may indicate positive market sentiment.
  • EssilorLuxottica Société anonyme has demonstrated strong trading volume, with a significant increase in shares traded recently, suggesting heightened investor interest.
  • The company maintains a low debt-to-equity ratio of 0.17, indicating a strong balance sheet and lower financial risk, which can be attractive to investors.
  • With a current ratio of 0.95, the company is close to having enough assets to cover its liabilities, reflecting good short-term financial health.
  • EssilorLuxottica Société anonyme operates in a diverse market, designing and distributing a wide range of optical products, which can help mitigate risks associated with market fluctuations.

EssilorLuxottica
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in EssilorLuxottica Société anonyme for these reasons:

  • The company has recently cut its dividend, which may signal financial strain or a shift in strategy that could concern income-focused investors.
  • Despite a recent increase in stock price, the stock has shown volatility, which may pose risks for investors looking for stable returns.
  • The quick ratio of 0.65 indicates that the company may have some challenges in meeting its short-term obligations, which could be a red flag for potential investors.
  • Market conditions can be unpredictable, and the optical industry may face challenges from economic downturns or changes in consumer preferences.
  • Investors may be cautious due to the company's reliance on global markets, which can be affected by geopolitical tensions and trade policies.

ESLOY Forecast - Frequently Asked Questions

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for EssilorLuxottica in the last twelve months. There is currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ESLOY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ESLOY, but not buy additional shares or sell existing shares.

According to analysts, EssilorLuxottica's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Analysts like EssilorLuxottica less than other "medical" companies. The consensus rating for EssilorLuxottica is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ESLOY compares to other companies.


This page (OTCMKTS:ESLOY) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners